Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

NCT03028285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Vascular Disease

Interventions

DRUG: arginine sodium succinate

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company